Related Experiment Video
Updated: Jun 15, 2025
Multi-modal Pulmonary Imaging: Using Complementary Information from CT and Hyperpolarized 129Xe MRI to Evaluate Lung Structure-Function
Published on: April 12, 2024
Platelet activation and COPD-related clinical and imaging characteristics: The Multi-Ethnic Study of Atherosclerosis
Carrie L Pistenmaa1, Eric A Hoffman2, Martin R Prince3
1Columbia University, New York, NY, USA; Brigham and Women's Hospital, Boston, MA, USA.
Introduction:
The pulmonary vasculature has been implicated in chronic obstructive pulmonary disease (COPD). Whether platelet activation is associated with COPD-related characteristics is unknown.
Methods:
The Multi-Ethnic Study of Atherosclerosis (MESA) COPD Study enrolled participants with 10+ pack-years with and without COPD from 2 cohort studies. Platelet activation was measured in platelet-free plasma as von Willebrand factor (vWF), beta-thromboglobulin (BTG) and platelet factor 4 (PF4). Phenotyping included spirometry, percent emphysema-950HU, air trapping on computed tomography (CT), low-ventilated lung volume on 3He-magnetic resonance imaging (MRI) and contrast-enhanced MRI pulmonary perfusion on and off oxygen. Linear and logistic regression adjusted for demographics, anthropometry, platelet count, aspirin use, COPD status and cohort; the final model adjusted for smoking, pack-years, oxygen saturation and hypertension.
Results:
The 116 with vWF were a mean age of 73.5 ± 7.3 years old, 60 % male, 58 % Non-Hispanic White, 28 % Black, 14 % Hispanic/Latino, 23 % smoked currently and 55 % had COPD. vWF was associated with lower FEV1/FVC (-2.0 %/SD vWF, 95 %CI: -3.5, -0.6), and greater percent low-ventilated lung volume on 3He-MRI (6.5 %/SD vWF, 95 %CI: 1.5, 11.5), CT air trapping (3.2 %/SD vWF, 95 %CI: 1.4, 5.1) and heterogeneity (CV) of pulmonary microvascular blood flow (PMBF) and pulmonary microvascular blood volume (PMBV) on oxygen. Higher BTG and PF4 were associated with greater PMBF and PMBV. There was increased odds of COPD with higher PF4 (final model only: OR 1.8/SD PF4, 95 %CI: 1.01, 3.20).
Conclusions:
Platelet activation was associated with measures of small airways disease and pulmonary microvascular perfusion in this sample of smokers with and without COPD.
Related Concept Videos
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
01:20COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
01:22Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD: